EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men

Ashley Kieran Clift iD, Hans Johnson iD, David R Huang iD, Abraham Morgentaler iD

The World Journal of Men's Health · 2026 · 44 (2) · 438

DOI: 10.5534/wjmh.250245 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The World Journal of Men's Health, 2026. Verfasst von Ashley Kieran Clift und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Menwell Ltd, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Trials of testosterone therapy (TTh) focus on transdermal or intramuscular preparations. In clinical practice, a range of administrations are utilised, often with adjunct therapies, but evidence is limited. This study characterised the safety and effectiveness of TTh over 12 months in a real-world setting. MATERIALS AND METHODS: A retrospective cohort study of adults treated by a men's health provider in the United Kingdom for testosterone deficiency between 2019 and 2024. Mixed effects models and Kaplan-Meier methodology were used. Changes in total testosterone, free testosterone, haematocrit, and quality of life (QoL; Likert scales of 1-5) domains over 12 months were evaluated overall and by baseline testosterone-defined groups. RESULTS: The cohort comprised 9,537 men (median age 42 years). Mean follow-up was 8.47 months. 8,517 were treated with sub-cutaneous testosterone injections (89.20%), 366 were prescribed transdermal testosterone (3.84%), 7,079 were prescribed human chorionic gonadotropin (75.23%), 675 (7.08%) were prescribed clomiphene citrate, and 1,308 (13.72%) were prescribed tadalafil (men may have received >1 treatment). Significant increases were observed in all 8 QoL domains, e.g., +1.26 points (95% confidence interval [CI]: 1.01 to 1.43) for libido. The mean increase in haematocrit by month 12 was 0.03 L/L (95% CI: 0.03 to 0.03). Trends and magnitude of increases in total and free testosterones and QoL did not differ between biochemical categories, with no difference in the rate of haematocrit exceeding 0.54 (p=0.18). CONCLUSIONS: TTh in a 'real-world setting' had a favourable safety profile and was associated with significant increases in men's sexual function, energy levels, life enjoyment, and performance in both work and sport. Future studies should support development of nuanced algorithms considering age, symptom severity and testosterone profiles to identify men likely to benefit from TTh.

Schlagwörter

Stichwörter der Autor:innen

Cohort studiesHypogonadismLongitudinal studiesTestosterone

Autor:innen und Institutionen

  • Department of Clinical Research, Menwell Ltd, London, UK.
  • Department of Surgery and Cancer, Imperial College London, London, UK. ashleyc@manual.co.
  • Department of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Ashley Kieran Clift, Hans Johnson, David R Huang, Abraham Morgentaler

Zitieren

APA

Clift, A. K., Johnson, H., Huang, D. R., & Morgentaler, A. (2026). Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men. The World Journal of Men's Health, 44(2), 438. https://doi.org/10.5534/wjmh.250245

Vancouver

Clift AK, Johnson H, Huang DR, Morgentaler A. Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men. The World Journal of Men's Health. 2026;44(2):438. doi:10.5534/wjmh.250245

BibTeX
@article{Clift2026,
  author = {Clift, Ashley Kieran and Johnson, Hans and Huang, David R and Morgentaler, Abraham},
  title = {Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men},
  journal = {The World Journal of Men's Health},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {438},
  doi = {10.5534/wjmh.250245}
}
Kostenlos starten →